Résumés
Résumé
Il est désormais acquis que la plasticité neuronale est importante, même chez l’adulte, pour la formation de nouvelles connexions comme pour celle de nouveaux neurones (neurogenèse) ou de cellules gliales. Cependant, le vieillissement et les facteurs de stress peuvent altérer cette plasticité et favoriser le développement d’une atrophie cérébrale. Des anomalies de plasticité neuronale pourraient être l’un des facteurs contribuant au développement des maladies neuropsychiatriques, et ce aux différents stades de la vie. La compréhension de ces processus, l’étude de leur implication dans la pathologie neuropsychiatrique et la recherche d’agents pharmacologiques à visée thérapeutique susceptibles de moduler cette plasticité neuronale constitue un des thèmes centraux de la recherche en neurosciences au sein de l’Institut de Recherches Servier.
Summary
Neuronal plasticity is now known to be very important in the adult, both in the formation of new synaptic connections and of new neurones (neurogenesis) and of glial cells. However, old age and stress can inhibit this plasticity and lead to cerebral atrophy. The time course of changes in neuronal plasticity involves, in the first milliseconds to seconds, changes in synaptic strength (long term potentialisation, LTP, or long term depression, LTD), then, over minutes to hours, changes in the number of synaptic connections (linked to changes in neurotrophic factors), and over weeks to months, to changes in neuronal reconfiguration. These changes in brain systems are particularly targeted in psychiatric disorders to the areas which are sensitive to stress and play roles in memory and emotion (hippocampus, amygdala and prefrontal cortex). The discovery and development of drugs modifying neuronal plasticity and neurotrophins production has been a priority for Servier research for the last ten years ; Servier has a clinically effective antidepressant, tianeptine (Stablon®), with a favourable side effect profile, but which does not inhibit the uptake of serotonin, or other monoamines. However, this drug can reverse the deleterious effects of stress on neuronal plasticity, thereby acting on the causes of psychiatric disorders. Furthermore, a new research area is being investigated - facilitation of AMPA receptors, favouring the production of neurotrophic factors.
Parties annexes
Références
- 1. Knott GW, Quairiaux C, Genoud C, Welker E. Formation of dendritic spines with GABAergic synapses induced by whisker stimulation in adult mice. Neuron 2002 ; 34 : 265-73.
- 2. Kempermann G, Gast D, Gage FH. Neuroplasticity in old age : Sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment. Ann Neurol 2002 ; 52 : 135-43.
- 3. Rocher C, Spedding M, Munoz C, Jay TM. Acute stress-induced changes in hippocampal/prefrontal circuits in rats : Effects of antidepressants. Cereb Cortex 2004 ; 14 : 224-9.
- 4. McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999 ; 22 : 105-22.
- 5. Reagan LP, Rosell DR, Wood GE, et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus : Reversal by tianeptine. Proc Natl Acad Sci USA 2004 ; 101 : 2179-84.
- 6. Rutter ML. Psychosocial adversity and child psychopathology. Br J Psychiatry 1999 ; 174 : 480-93.
- 7. Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 2001 ; 24 : 1161-92.
- 8. Mayberg HS. Limbic-cortical dysregulation : A proposed model of depression. JNeuropsychiatry Clin Neurosci 1997 ; 9 : 471-81.
- 9. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999 ; 45 : 1085-98.
- 10. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999 ; 19 : 5034-43.
- 11. Duman RS, Charney DS. Cell atrophy and loss in major depression. Biol Psychiatry 1999 ; 45 : 1083-4.
- 12. Bremner JD, Vythilingam M, Vermetten E, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002 ; 51 : 273-9.
- 13. Andriamampandry C, Muller C, Schmidt-Mutter C, et al. Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonic. Mol Pharmacol 2002 ; 62 : 1332-8.
- 14. Shakesby AC, Anwyl R, Rowan MJ. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus : Rapid actions of serotonergic and antidepressant agents. J Neurosci 2002 ; 22 : 3638-44.
- 15. Diamond DM, Campbell A, Park CR, Vouimba RM. Preclinical research on stress, memory and the brain in the development of pharmacotherapy for depression. Eur J Neuropsychopharmacol 2004 ; 14 : S491-5.
- 16. Cassano GB, Heinze G, Lôo H, et al. A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes. Eur Psychiatry 1996 ; 11 : 254-9.
- 17. Morris RG, Kelly S, Burney D, et al. Tianeptine and its enantiomers : Effects on spatial memory in rats with medial septum lesions. Neuropharmacology 2001 ; 41 : 272-81.
- 18. Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001 ; 98 : 12796-801.
- 19. Kole MH, Swan L, Fuchs E. The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci 2002 ; 16 : 807-16.
- 20. Ito I, Tanabe S, Kohda A, Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol(Lond) 1990 ; 424 : 533-43.
- 21. Lebrun C, Pilliere E, Lestage P. Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats. Eur J Pharmacol 2000 ; 401 : 205-12.
- 22. Lockhart B, Iop F, Closier M, Lestage P. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide : (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated 3H noradrenaline release from rat hippocampal and frontal cortex slices. Eur J Pharmacol 2000 ; 401 : 145-53.
- 23. Arai AC, Xia YF, Rogers G, et al. Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. J Pharmacol Exp Ther 2002 ; 303 : 1075-85.
- 24. Lauterborn JC, Lynch G, Vanderklish P, et al. Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci 2000 ; 20 : 8-21.
- 25. Dicou E, Rangon CM, Guimiot F, et al. Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain. Brain Res 2003 ; 970 : 221-5.
- 26. Tardin C, Cognet L, Bats C, et al. Direct imaging of lateral movements of AMPA receptors inside synapses. EMBO J 2003 ; 22 : 4656-65.
- 27. Barry MF, Ziff EB. Receptor trafficking and the plasticity of excitatory synapses. Curr Opin Neurobiol 2002 ; 12 : 279-86.
- 28. Buzsaki G. Theta oscillations in the hippocampus. Neuron 2002 ; 33 : 325-40.
- 29. Rogan MT, Staubli UV, LeDoux JE. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 1997 ; 390 : 604-7.
- 30. Marrone DF, Petit TL. The role of synaptic morphology in neural plasticity : structural interactions underlying synaptic power. Brain Res Brain Res Rev 2002 ; 38 : 291-308.